Results 261 to 270 of about 55,492 (285)

Deferoxamine in Thalassemia Major

New England Journal of Medicine, 1995
N ...
Splendiani G., Tozzo C., Mazzarella V., Casciani C. U., Lucarelli G., Angelucci E., Clift R., Cazzola M., Locatelli F., de Stefano P., Olivieri N. F., Nathan D. G., Cohen A. R.   +12 more
openaire   +3 more sources

Cholelithiasis in Thalassemia Major

Radiology, 1970
Abstract In a study of patients with thalassemia major by oral cholecystography, the incidence of cholelithiasis is determined. Six of 26 patients aged ten years and older have biliary calculi; in addition, gallstones have been demonstrated during life or at autopsy in 7 of 35 who have died. The association of gallstones with thalassemia, less frequent
Virginia C. Canale, Kermit W. Dewey, Herman Grossman   +2 more
openaire   +3 more sources

Heterogeneity of Thalassemia Major

Archives of Pediatrics & Adolescent Medicine, 1963
Previous communications1,2concerning A2hemoglobin in parents of subjects with thalassemia major reported normal levels in a small minority. Fetal hemoglobin percentage was determined in some of these individuals and was noted to be unexpectedly high in all but one.
Valentina G. Ignatov, James A. Wolff
openaire   +3 more sources

Complications of thalassemia major and their treatment

Expert Review of Hematology, 2011
The life of patients with thalassemia has improved both in duration and in quality in industrialized countries. Complications are still common and include heart disease (heart failure and arrhythmias), chronic liver hepatitis, which can evolve in cirrhosis and, rarely, in hepatocellular carcinoma, endocrine problems (hypogonadism, hypothyroidism ...
BORGNA, Caterina, M. R. Gamberini
openaire   +2 more sources

Echocardiographic findings in thalassemia major

Acta Paediatrica, 1994
[No abstract available]
Kilinc Y., Acarturk E., Kumi M., Antmen B., Yilmaz L.   +4 more
openaire   +4 more sources

Psychosocial implications of Thalassemia Major

Pediatrics International, 2005
Abstract  Background : Many causes including the chronicity of disease, burden of treatment modalities, morbidities, and the expectation of early death resulting from the disease complications, may lead to psychosocial burden in Thalassemia Major (TM) patients.
Erermis S., Aydinok Y., Bukusoglu N., Yilmazi D., Solak U.   +4 more
openaire   +4 more sources

Iron Chelation in Thalassemia Major

Clinical Therapeutics, 2015
Iron chelation has improved survival and quality of life of patients with thalassemia major. there are currently 3 commercially available iron-chelating drugs with different pharmacokinetic and pharmacodynamic activity. The choice of adequate chelation treatment should be tailored to patient needs and based on up-to-date scientific evidence.A review of
BORGNA, Caterina, Marsella, M.
openaire   +2 more sources

Hypogonadism in Thalassemia Major.

Blood, 2005
Abstract Thalassemia is one of the commonest hereditary hemolytic anemia. 3% to 17% of the population in Indian subcontinent carries beta thalassemia gene. Every year about 100,000 children are born with thalassemia major in the world. Out of these 8000 to10,000 are born in India.
Anupam Sachdeva, Archana D. Arya, Varinder Kumar Khanna, Satya Prakash Yadav, Subhash Chander Arya   +4 more
openaire   +2 more sources

Myopathological Findings in Thalassemia Major

European Neurology, 1990
In thalassemia major (TM) one third of patients suffers from muscle wasting, weakness and cramps. Six patients with TM were studied. All had muscle wasting and proximal weakness; serum levels of vitamin E were low (0.6-7.0 micrograms/dl) while CPK, LDH and aldolase were normal.
E. Rosenmann, A. Goldfarb, Y. Shapira, B. Glick, A. Finsterbush   +4 more
openaire   +3 more sources

Cardiovascular MRI in thalassemia major

Annals of the New York Academy of Sciences, 2010
MRI assessment of myocardial iron and function has revolutionized the treatment of thalassemia major patients. While knowledge of somatic iron stores is vital for iron chelation management, it does not adequately monitor cardiac risk. MRI monitoring of cardiac T2* allows preclinical recognition of myocardial iron, stratifies prospective cardiac risk ...
John C. Wood, Leila Noetzli
openaire   +3 more sources